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INTRODUCTION 
Physiologic effects of high flow nasal cannula (HFNC) include CO2 washout from the upper 
airways, reduction of the work of breathing (1-2) and generation of positive end-expiratory 
pressure (PEEP) (3-4). However, the PEEP level obtained by HFNC is relatively low (i.e., 2-5 
cmH2O), very difficult to measure in clinical practice and predictably unstable (i.e., PEEP 
may vary with patient’s mouth opening) (3-6). The HELMET is an interface designed to 
deliver non-invasive positive pressure ventilation or continuous positive airway pressure 
(CPAP) in a more comfortable and effective way than facial masks (7-8). The PEEP level 
generated in the HELMET is in the 5-15 cmH2O range, easily measurable at the bedside and 
independent from mouth opening. However, previous studies showed that low levels of CO2 
can accumulate within the helmet, potentially leading to CO2 re-breathing and additional 
workload for the patient (7-8). In summary, with HFNC, flow is set, and pressure is variable, 
while with HELMET CPAP, pressure is set and flow is variable. 
We reasoned that a coupled HFNC+HELMET system could combine the positive effects of 
each support (i.e., CO2 washout and reduced re-breathing + high measurable stable PEEP) 
and herein report preliminary data on healthy volunteers. 
 
METHODS 
The Ethical Committee of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore 
Policlinico, Milan, Italy, approved the study (reference number: 431/2016) and informed 
consent was obtained. Healthy volunteers were recruited from medical students and 
anesthesia residents from our hospital unaware of the study design and hypothesis (e.g., none 
of the authors of the present article acted as volunteer and none of the students or residents 
enrolled were involved in ventilation-related clinical research activities). 
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A custom-made system to deliver HFNC within a sealed HELMET connected to a water 
PEEP valve was developed (HFNC flow 50 l/min, temperature 31 °C and external PEEP 8 
cmH2O): HFNC (AIRVO
TM
 2, Fisher & Paykel Healthcare, Auckland, New Zealand) was 
passed through an existing port in the lower part of a commercially available HELMET 
(StarMed CaStar Up, Intersurgical Ltd. Wokingham, UK) and sealed by an appropriate rubber 
gasket; the standard inlet port of the HELMET was closed and sealed, while respiratory 
tubing connected the expiratory port to a water PEEP valve.  
Five healthy volunteers (study no. 1) were kept in semi-recumbent position and a small-bore 
plastic tube was positioned through a sealed hole inside the HFNC+HELMET system, close 
to the mouth. Waveforms of airway pressure (Paw) inside the HFNC+HELMET were 
recorded on a computer for subsequent analysis by dedicated system (Colligo, Elekton, Milan, 
Italy). FiO2 was 0.30, flow 50 l/min and temperature 31 °C. Each subject underwent three 
study phases (random order, 15 minutes) at external PEEP of 3, 5 and 8 cmH2O. Towards the 
end, we measured vital signs, comfort (by a numeric 0-10 scale), mean Paw (Pawm) and the 
average Paw excursion (∆Paw) during the respiratory cycle.  
Eight healthy volunteers (study no. 2) were kept in semi-recumbent position and a small-bore 
plastic tube was advanced through a nostril to the hypopharynx. Waveforms of the CO2 
tension were recorded through this tube for 2-3 minutes at the end of each study phase 
(ORIDION Capnostream™ C35 Medtronic, Minneapolis, MN) while EIT data (PulmoVista® 
500, Dräger Medical GmbH, Lübeck, Germany) were continuously recorded. Each subject 
underwent the following phases (random order, 15 minutes, FiO2 0.30): 
- Standard HFNC at 50 l/min and 31 °C; 
- Standard HELMET CPAP, with flow 50 L/min, no active humidification and external PEEP 
8 cmH2O; 
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- Combined HFNC+HELMET system, flow 50 l/min, temperature 31 °C and external PEEP 8 
cmH2O. 
Towards the end, we recorded vital signs, comfort, the average inspiratory and expiratory CO2 
levels (PiCO2 and PeCO2) and, from EIT, global, non-dependent and dependent tidal volumes 
(VT, glob, VT, non-dep and VT, dep); ventilation heterogeneity (Vtnon-dep/Vtdep ratio); minute 
ventilation (MV); corrected minute ventilation (MVcorr = MV*[actual PeCO2/40 mmHg]); 
global and regional changes in end-expiratory lung impedance (∆EELIglob, ∆EELInon-dep and 
∆EELIdep) (3-4).  
Study sample size was chosen based on previous studies (7, 8). Given the small samples size, 
differences between variables across study phases were tested by by one-way repeated 
measures ANOVA on ranks. Tukey test was used for post-hoc correction (SigmaPlot 11.0, 
Systat Software Inc., San Jose, CA). 
 
RESULTS 
Pawm within the HFNC+HELMET system at three levels of external PEEP (3, 5 and 8 
cmH2O) closely corresponded to the set PEEP level and Paw oscillations during the 
respiratory cycle were very small (Table 1), indicating that the HFNC+HELMET system 
effectively provides high, stable and measurable PEEP. All the subjects tolerated well the 
HFNC+HELMET system at increasing PEEP levels (Table 1). 
PiCO2 measured at the hypopharynx level was significantly higher during the standard 
HELMET phase than with HFNC and the HFNC+HELMET system, which had similar very 
low values (Table 2). Respiratory rate and minute ventilation were significantly higher during 
the standard HELMET phase in comparison with HFNC and HFNC+HELMET, which were 
lower and similar (Table 2). PeCO2 (i.e., the closest surrogate for arterial CO2 tension in this 
study) wasn’t increased during HFNC and HFNC+HELMET in comparison to standard 
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HELMET despite reduced ventilation, thus yielding significantly reduced VMcorr (Table 2). 
The decrease in minute ventilation was mainly driven by a reduction in respiratory rate, while 
global and regional Vt did not change significantly. End-expiratory lung volume, as assessed 
by ∆EELI, significantly increased during HELMET and HFNC+HELMET phases, globally 
and in the dependent and non-dependent lung regions, suggesting a homogenous distribution 
typical of healthy subjects. The increase in lung volume was similar between standard 
HELMET and HFNC+HELMET (Table 2), once again indicating comparable PEEP level 
delivered by the two systems. Vital parameters and comfort remained stable with all the three 
modes of respiratory support (Table 2). 
 
DISCUSSION 
The novel HFNC+HELMET system, delivering nasal high flow within a sealed helmet 
connected to a PEEP valve, provides a clinically relevant, measurable and stable PEEP. 
Moreover, the HFNC+HELMET system grants effective CO2 washout from upper airways, 
with negligible CO2 re-breathing and enhanced CO2 clearance.  
Previous studies showed that increasing lung volume by standard HELMET (9) and lowering 
dead space by HFNC (10) might reduce intubation rate of acute hypoxemic respiratory failure 
(AHRF) patients. Thus, the present studies generate the hypothesis that the combined 
HFNC+HELMET system may enhance our ability to avoid intubation and all the attendant 
risks of invasive mechanical ventilation in AHRF.  
The present studies have relevant limitations: they were performed in a small sample of 
healthy volunteers and their results may not apply to AHRF patients; key physiologic 
variables like inspiratory effort and transpulmonary pressure were not investigated; study 
phases were short and longer-term effects could differ (e.g., patients’ comfort within the new 
HFNC+HELMET might be poorer than with standard HFNC limiting long-term application); 
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in the clinical setting, HFNC+HELMET may mask signs of deteriorating respiratory function 
and delay intubation, yielding poorer clinical outcomes; previous studies (7, 8) showed that, 
when the fresh gas flow is set above 30 l/min, CO2 rebreathing within the HELMET CPAP 
system might be negligible and the new HFNC+HELMET system less useful.  
In conclusion, the combination of HFNC+HELMET might present additive physiologic 
effects, potentially representing a new non-invasive respiratory support. Further studies in 
AHRF patients are needed to replicate the present findings and to assess the effects of 
HFNC+HELMET on arterial CO2 tension (in hypercapnic patients) and on recruitment, 
oxygenation and the respiratory drive (in hypoxemic patients). 
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TABLES 
Table 1. Results from study no. 1 (see text for details): variables measured at 3 different 
set PEEP levels during support by the novel HFNC+HELMET system. 
Variable 
Set PEEP: 
3 cmH2O 
n=5 
Set PEEP: 
5 cmH2O 
n=5 
Set PEEP: 
8 cmH2O 
n=5 
P-value 
Pawm, cmH2O 3.2 [2.8-3.5] 5.4 [5.4-6.0] 8.2 [8.1-8.5]* <0.001 
∆Paw, cmH2O 1.0 [0.7-1.1] 0.8 [0.6-1.1] 0.7 [0.4-1.0] 0.522 
SpO2, % 100 [99-100] 99 [99-100] 99 [99-100] 0.954 
RR, breaths/min 15.0 [11.5-18.0] 12.0 [9.0-14.5] 12.0 [5.0-16.0] 0.182 
HR, bpm 60 [51-67] 60 [52-73] 63 [53-68] 0.124 
SBP, mmHg 131.0 [123-150] 138.0 [124-145] 141.0 [127-155] 0.367 
DBP, mmHg 87.0 [76-93] 92.0 [83-93] 93.0 [83-97] 0.182 
Comfort (0-10), n 7.0 [7.0-9.0] 6.0 [5.0-9.0] 7.0 [5.5-8.5] 0.367 
 
Variables are expressed as median and interquartile range [IQR]. P-values refer to Friedman 
Repeated Measures Analysis of Variance on Ranks. Post-Hoc Multiple Comparison 
Procedures (Tukey Test on ranks):  
* p <0.001 vs. PEEP 3 cmH2O 
 
PEEP: positive end expiratory pressure; Pawm: mean airway pressure inside the 
HFNC+HELMET system; ∆Paw: average Paw excursion during the respiratory cycle; SpO2: 
peripheral arterial O2 saturation; RR: respiratory rate; HR: heart rate; SBP: systolic blood 
pressure; DBP: diastolic blood pressure. 
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Table 2. Results from study no. 2 (see text for details): effects of the 3 non-invasive 
respiratory support systems on vital signs, ventilation, CO2 clearance, and lung volumes. 
Variable 
HFNC 
n=8 
HELMET 
n=8 
HFNC+ 
HELMET 
n=8 
P-value 
SpO2, % 100 [99-100] 100 [99-100] 100 [99-100] 1.000 
RR, breaths/min 8.5 [6.3-10.0] 14.5 [9.0-17.0]* 10.0 [5.5-11.8]† 0.010 
HR, bpm 67 [62-73] 69 [64-80] 70 [68-76] 0.355 
SBP, mmHg 117 [107-124] 123 [113-131]* 127 [113-131]* <0.001 
DBP, mmHg 74 [73-79] 79 [74-82] 77 [74-82] 0.531 
Comfort (0-10), n 8.0 [6.0-8.0] 8.0 [6.0-8.0] 7.0 [4.5-8.0] 0.654 
PiCO2, mmHg 0.01 [0.00-0.12] 1.72 [1.46-3.92]* 0.06 [0.00-0.79]† <0.001 
PeCO2, mmHg 34.0 [26.3-38.5] 36.7 [35.2-37.9] 33.5 [26.5-39.3] 1.000 
Vtglob, a.u. 4152 [3625-7207] 3558 [3111-7036] 4689 [3054-6843] 0.654 
Vtglob, change vs. 
HFNC phase, % 
Ref. -8.7 [(-40.2)-32.9] 15.6 [(-28.4)-77.6] 0.654 
Vtnon-dep, a.u. 2036 [1537-3881] 1735 [1587-4208] 1670 [1513-4799] 0.794 
Vtnon-dep, change vs. 
HFNC phase, % 
Ref. -12.6[(-46.8)-35.1] -8.5 [(-36.8)-79.3] 0.794 
Vtdep, a.u. 2388 [1675-2922] 1894 [1670-2841] 2463 [1553-3558] 0.355 
Vtdep, change vs. 
HFNC phase, % 
Ref. -5.6 [(-32.9)-30.4] 12.8 [(-28.1)-75.3] 0.355 
Vtnon-dep/Vtdep ratio 1.2 [0.8-1.3] 1.0 [0.7-1.6] 1.0 [0.6-1.4] 0.531 
MV, a.u. 
36049 
[32170-44372] 
54344 
[43061-61904] 
39241 
[32071-44941] 
0.038 
MV, change vs. 
HFNC phase, % 
Ref. 46 [23- 85] 3 [(-20)-22] 0.038 
MVcorr, a.u. 
31941 
[28980-35343] 
47723 
[41033-56663] 
30326 
[26318-36169]† 
0.005 
MVcorr change vs. 
HFNC phase, % 
Ref. 58 [20- 98] -7 [(-12)-25]† 0.005 
∆EELIglob, a.u. Ref. 5682 [2821-8222]* 5959 [4793-8414]* <0.001 
∆EELInon-dep, a.u. Ref. 3905 [1933-4809]* 3938 [3323-5769]* <0.001 
∆EELIdep, a.u. Ref. 1774 [1217-3412]* 2213 [1476-3065]* 0.008 
 
Variables are expressed as median and interquartile range [IQR]. P-values refer to Friedman 
Repeated Measures Analysis of Variance on Ranks. Post-Hoc Multiple Comparison 
Procedures (Tukey Test on ranks):  
* p <0.05 vs. HFNC;  
† p <0.05 vs. HELMET. 
 
HFNC: standard high flow nasal cannula with 50 l/min flow; HELMET: standard HELMET 
CPAP system with fresh inlet gas flow of 50 l/min and connected to water valve with PEEP 8 
cmH2O; HFNC+HELMET: novel system with HFNC at 50 l/min delivered inside sealed 
HELMET connected to water valve with PEEP 8 cmH2O; SpO2: peripheral arterial O2 
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saturation; RR: respiratory rate; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic 
blood pressure; PiCO2: inspiratory CO2 pressure; PeCO2: expiratory CO2 pressure; Vtglob: 
tidal volume distending the respiratory system meacured by EIT; a.u.: arbitrary units of 
impedance change; Vtnon-dep: tidal volume distending the non-dependent region; Vtdep: tidal 
volume distending the dependent region; MV: minute ventilation; MVcorr: corrected minute 
ventilation; ∆EELIglob: change in end-expiratory lung impedance from the HFNC baseline 
phase; ∆EELInon-dep: change in end-expiratory lung impedance of the non-dependent region; 
∆EELIdep: change in end-expiratory lung impedance of the dependent region; 
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